MSLE · Satellos Bioscience Inc.
Market Cap
$203.89M
Shares
21.22M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Diluted EPS
-$1.70
+21.3%
FY2025
Operating Cash Flow
-$23.6M
-29.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| $4000 | $15K | |
| -$24.7M | -$20.63M | |
| $172K | — | |
| USD/shares | -$1.70 | -$2.16 |
| USD/shares | -$1.70 | -$2.16 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Key facts
CIK
1421642
CUSIP
80401L803
13F (30d)
25 filings
25 filers
Visit website
Investor relations